J&J, Hopeful On COVID-19 Vaccine Outlook, Looks To Restore Public Confidence

 
• By Jessica Merrill
  
Janssen vaccine
J&J recorded $100m in COVID-19 vaccine sales in the first quarter • Source: Alamy (Markus Mainka / Alamy Stock Phot/Alamy Stock Photo)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip